|
1
|
Batash R, Asna N, Schaffer P, Francis N
and Schaffer M: Glioblastoma multiforme, diagnosis and treatment;
recent literature review. Curr Med Chem. 24:3002–3009. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ricard D, Idbaih A, Ducray F, Lahutte M,
Hoang-Xuan K and Delattre JY: Primary brain tumours in adults.
Lancet. 379:1984–1996. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dalessio A, Proietti G, Sica G and
Scicchitano BM: Pathological and molecular features of glioblastoma
and its peritumoral tissue. Cancers (Basel). 11:4692019. View Article : Google Scholar
|
|
4
|
Louis DN, Perry A, Reifenberger G, von
Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD,
Kleihues P and Ellison DW: The 2016 World health organization
classification of tumors of the central nervous system: A summary.
Acta Neuropathol. 131:803–820. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Carlsson SK, Brothers SP and Wahlestedt D:
Emerging treatment strategies for glioblastoma multiforme. EMBO Mol
Med. 6:1359–1370. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Aldape KD, Brindle KM, Chesler L, Chopra
R, Gajjar A, Gilbert MR, Gottardo N, Gutmann DH, Hargrave D,
Holland EC, et al: Challenges to curing primary brain tumours. Nat
Rev Clin Oncol. 16:509–520. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Brandao M, Simon T, Critchley G and Giamas
G: Astrocytes, the rising stars of the glioblastoma
microenvironment. Glia. 67:779–790. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Osti D, De Bene MD, Rappa G, Santos M,
Matafora V, Richichi C, Faletti S, Beznoussenko GV, Mironov A,
Bachi A, et al: Clinical significance of extracellular vesicles in
plasma from glioblastoma patients. Clin Cancer Res. 25:266–276.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Isobe T, Hisamori S, Hogan DJ, Zabala M,
Hendrickson DG, Dalerba P, Cai S, Scheeren F, Kuo AH, Sikandar SS,
et al: miR-142 regulates the tumorigenicity of human breast cancer
stem cells through the canonical WNT signaling pathway. Elife.
3:e019772014. View Article : Google Scholar
|
|
10
|
Ghosh D, Ulasov IV, Chen L, Harkins LE,
Wallenborg K, Hothi P, Rostad S, Hood L and Cobbs CS:
TGFβ-responsive HMOX1 expression is associated with stemness and
invasion in glioblastoma multiforme. Stem Cells. 34:2276–2289.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang X, Li W, Kang Y, Zhang J and Yuan H:
SynCAM, a novel putative tumor suppressor, suppresses growth and
invasiveness of glioblastoma. Mol Biol Rep. 40:5469–5475. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Murakami Y: Involvement of a cell adhesion
molecule, TSLC1/IGSF4, in human oncogenesis. Cancer Sci.
96:543–552. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kikuchi S, Iwai M, Sakurai-Yageta M,
Tsuboi Y, Ito T, Maruyama T, Tsuda H, Kanai Y, Onizuka M, Sato Y
and Murakami Y: Expression of a splicing variant of the CADM1
specific to small cell lung cancer. Cancer Sci. 103:1051–1057.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Vallath S, Sage EK, Kolluri KK, Lourenco
SN, Teixeira VS, Chimalapati S, George PJ, Janes SM and Giangreco
A: CADM1 inhibits squamous cell carcinoma progression by reducing
STAT3 activity. Sci Rep. 6:240062016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gregory RI, Chendrimada TP and Shiekhattar
R: MicroRNA biogenesis: Isolation and characterization of the
microprocessor complex. Methods Mol Biol. 342:33–47.
2006.PubMed/NCBI
|
|
16
|
Krol J, Loedige I and Filipowicz W: The
widespread regulation of microRNA biogenesis, function and decay.
Nat Rev Genet. 11:597–610. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lee YS and Dutta A: MicroRNAs in cancer.
Annu Rev Pathol. 4:199–227. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Dong Z and Cui H: Epigenetic modulation of
metabolism in glioblastoma. Semin Cancer Biol. 57:45–51. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Candido S, Lupo G, Pennisi M, Basile MS,
Anfuso CD, Petralia MC, Gattuso G, Vivarelli S, Spandidos DA, Libra
M and Falzone L: The analysis of miRNA expression profiling
datasets reveals inverse microRNA patterns in glioblastoma and
Alzheimer's disease. Oncol Rep. 42:911–922. 2019.PubMed/NCBI
|
|
20
|
Ye X, Wei W, Zhang Z, He C, Yang R, Zhang
J, Wu Z, Huang Q and Jiang Q: Identification of microRNAs
associated with glioma diagnosis and prognosis. Oncotarget.
8:26394–26403. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Guessous F, Alvaradovelez M, Marcinkiewicz
L, Zhang Y, Kim J, Heister S, Kefas B, Godlewski J, Schiff D, Purow
B and Abounader R: Oncogenic effects of miR-10b in glioblastoma
stem cells. J Neurooncol. 112:153–163. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang J, Liu H, Tian L, Wang F, Han L,
Zhang W and Bai YA: miR-15b inhibits the progression of
glioblastoma cells through targeting insulin-like growth factor
receptor 1. Horm Cancer. 8:49–57. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shi L, Chen J, Yang J, Pan T, Zhang S and
Wang Z: MiR-21 protected human glioblastoma U87MG cells from
chemotherapeutic drug temozolomide induced apoptosis by decreasing
Bax/Bcl-2 ratio and caspase-3 activity. Brain Res. 1352:255–264.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Silber J, Lim DA, Petritsch C, Persson AI,
Maunakea AK, Yu M, Vandenberg SR, Ginzinger DG, James CD, Costello
JF, et al: miR-124 and miR-137 inhibit proliferation of
glioblastoma multiforme cells and induce differentiation of brain
tumor stem cells. BMC Med. 6:142008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ergun S, Güney S, Temiz E, Petrovic N and
Gunes S: Significance of miR-15a-5p and CNKSR3 as novel prognostic
biomarkers in non-small cell lung cancer. Anticancer Agents Med
Chem. 18:1695–1701. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kontos CK, Tsiakanikas P, Avgeris M,
Papadopoulos IN and Scorilas A: miR-15a-5p, a novel prognostic
biomarker, predicting recurrent colorectal adenocarcinoma. Mol
Diagn Ther. 21:453–464. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang ZM, Wan XH, Sang GY, Zhao JD and Wang
DM: miR-15a-5p suppresses endometrial cancer cell growth via
Wnt/β-catenin signaling pathway by inhibiting WNT3A. Eur Rev Med
Pharmacol Sci. 21:4810–4818. 2017.PubMed/NCBI
|
|
28
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
29
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Karar J and Maity A: PI3K/AKT/mTOR pathway
in angiogenesis. Front Mol Neurosci. 4:512011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li X, Wu C, Chen N, Gu H, Yen A, Cao L,
Wang E and Wang L: PI3K/Akt/mTOR signaling pathway and targeted
therapy for glioblastoma. Oncotarget. 7:33440–33450. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Mao X, Seidlitz E, Ghosh K, Murakami Y and
Ghosh HP: The cytoplasmic domain is critical to the tumor
suppressor activity of TSLC1 in non-small cell lung cancer. Cancer
Res. 63:7979–7985. 2003.PubMed/NCBI
|
|
33
|
Chen H and Tian Y: MiR-15a-5p regulates
viability and matrix degradation of human osteoarthritis
chondrocytes via targeting VEGFA. Biosci Trends. 10:482–488. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Vivanco I and Sawyers CL: The
phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev
Cancer. 2:489–501. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
35
|
Pang K, Song J, Bai Z and Zhang Z:
miR-15a-5p targets PHLPP2 in gastric cancer cells to modulate
platinum resistance and is a suitable serum biomarker for
oxaliplatin resistance. Neoplasma. 67:1114–1121. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhang K, Zhong W, Li WP, Chen ZJ and Zhang
C: miR-15a-5p levels correlate with poor ovarian response in human
follicular fluid. Reproduction. 154:483–496. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Franke TF, Hornik CP, Segev L, Shostak GA
and Sugimoto C: PI3K/Akt and apoptosis: Size matters. Oncogene.
22:8983–8998. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Mirzaa GM, Campbell CD, Solovieff N, Goold
C, Jansen LA, Menon S, Timms AE, Conti V, Biag JD, Adams C, et al:
Association of MTOR mutations with developmental brain disorders,
including megalencephaly, focal cortical dysplasia, and pigmentary
mosaicism. JAMA Neurol. 73:836–845. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yang J, Pi C and Wang G: Inhibition of
PI3K/Akt/mTOR pathway by apigenin induces apoptosis and autophagy
in hepatocellular carcinoma cells. Biomed Pharmacother.
103:699–707. 2018. View Article : Google Scholar : PubMed/NCBI
|
